Payment overview · 2025
General Payments
$17.73
1 reported records · 1 companies
Healthcare provider profile · identity verified
Judith D Kinzy, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · KNOXVILLE, TN · NPI 1770508608
Verified facts
What the public records show
CMS Open Payments records show Judith D Kinzy, M.D. received $17.73 in general payments during 2025 across 1 reported records.
Salix Pharmaceuticals, a division of Bausch Health US, LLC accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $17.73 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.73 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 422 | 124 |
| Levothyroxine Sodium | Levothyroxine Sodium | 373 | 102 |
| Atorvastatin Calcium | Atorvastatin Calcium | 342 | 99 |
| Omeprazole | Omeprazole | 333 | 99 |
| Gabapentin | Gabapentin | 254 | 49 |
| Metoprolol Succinate | Metoprolol Succinate | 222 | 64 |
| Losartan Potassium | Losartan Potassium | 195 | 54 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 144 | 49 |
| Metformin Hcl | Metformin Hcl | 140 | 34 |
| Alprazolam | Alprazolam | 137 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 136 | 33 |
| Tramadol Hcl | Tramadol Hcl | 134 | 21 |
| Lisinopril | Lisinopril | 129 | 37 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 125 | 17 |
| Montelukast Sodium | Montelukast Sodium | 125 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 120 | 20 |
| Eliquis | Apixaban | 109 | 24 |
| Lorazepam | Lorazepam | 108 | 12 |
| Metformin Hcl Er | Metformin Hcl | 106 | 37 |
| Trazodone Hcl | Trazodone Hcl | 104 | 31 |
| Buspirone Hcl | Buspirone Hcl | 101 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 98 | 31 |
| Famotidine | Famotidine | 94 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 92 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 32 |
| Simvastatin | Simvastatin | 87 | 22 |
| Furosemide | Furosemide | 85 | 30 |
| Donepezil Hcl | Donepezil Hcl | 83 | 16 |
| Enalapril Maleate | Enalapril Maleate | 83 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 26 |
| Potassium Chloride | Potassium Chloride | 81 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 77 | 29 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 73 | 73 |
| Glimepiride | Glimepiride | 70 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 70 | 18 |
| Januvia | Sitagliptin Phosphate | 64 | 11 |
| Sertraline Hcl | Sertraline Hcl | 63 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 63 | 18 |
| Clonazepam | Clonazepam | 61 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | 15 |
| Memantine Hcl | Memantine Hcl | 56 | 12 |
| Ozempic | Semaglutide | 54 | suppressed |
| Bupropion Xl | Bupropion Hcl | 52 | 15 |
| Meloxicam | Meloxicam | 51 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 49 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 17 |
| Baclofen | Baclofen | 47 | suppressed |
| Estradiol | Estradiol | 47 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | 13 |
| Prednisone | Prednisone | 40 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 31 |
| Meclizine Hcl | Meclizine Hcl | 39 | 13 |
| Spironolactone | Spironolactone | 39 | 15 |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Carvedilol | Carvedilol | 38 | 13 |
| Methylprednisolone | Methylprednisolone | 38 | 34 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 38 | suppressed |
| Ondansetron Odt | Ondansetron | 37 | 11 |
| Atenolol | Atenolol | 36 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 36 | 36 |
| Allopurinol | Allopurinol | 35 | 11 |
| Ibandronate Sodium | Ibandronate Sodium | 35 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Pregabalin | Pregabalin | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 32 | 13 |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 26 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 29 | 14 |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Diazepam | Diazepam | 26 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 25 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 25 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 24 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Nystatin | Nystatin | 24 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Ramipril | Ramipril | 24 | suppressed |
| Acyclovir | Acyclovir | 23 | suppressed |
| Mirtazapine | Mirtazapine | 23 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 19 |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Fluconazole | Fluconazole | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Cefdinir | Cefdinir | 20 | 17 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Jardiance | Empagliflozin | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Telmisartan | Telmisartan | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 14 |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 17 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 11 |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Minoxidil | Minoxidil | 16 | suppressed |
| Repatha Sureclick | Evolocumab | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Rybelsus | Semaglutide | 15 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 14 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Repaglinide | Repaglinide | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.73 · 1 records | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error